Literature DB >> 30801050

Mismatch repair deficiency in high-grade meningioma: a rare but recurrent event associated with dramatic immune activation and clinical response to PD-1 blockade.

Ian F Dunn1, Ziming Du2,3, Sandro Santagata2,3,4,5, David A Reardon6,7, Mehdi Touat6,4, Michael B Sisti8, Patrick Y Wen9,7, Renato Umeton10, Adrian M Dubuc2, Matthew Ducar10,11, Peter D Canoll12, Eric Severson13, Julia A Elvin14, Shakti H Ramkissoon13,15, Jia-Ren Lin3,5, Lais Cabrera7, Brenda Acevedo7, Peter K Sorger3,5,16, Keith L Ligon2,6,4.   

Abstract

Entities:  

Year:  2018        PMID: 30801050      PMCID: PMC6383717          DOI: 10.1200/PO.18.00190

Source DB:  PubMed          Journal:  JCO Precis Oncol        ISSN: 2473-4284


× No keyword cloud information.
  17 in total

1.  NF2 mutation status and tumor mutational burden correlate with immune cell infiltration in meningiomas.

Authors:  John W Rutland; Corey M Gill; Joshua Loewenstern; Hanane Arib; Margaret Pain; Melissa Umphlett; Yayoi Kinoshita; Russell B McBride; Joshua Bederson; Michael Donovan; Robert Sebra; Raj K Shrivastava; Mary Fowkes
Journal:  Cancer Immunol Immunother       Date:  2020-07-13       Impact factor: 6.968

Review 2.  The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients.

Authors:  Craig Horbinski; Keith L Ligon; Priscilla Brastianos; Jason T Huse; Monica Venere; Susan Chang; Jan Buckner; Timothy Cloughesy; Robert B Jenkins; Caterina Giannini; Roger Stupp; L Burt Nabors; Patrick Y Wen; Kenneth J Aldape; Rimas V Lukas; Evanthia Galanis; Charles G Eberhart; Daniel J Brat; Jann N Sarkaria
Journal:  Neuro Oncol       Date:  2019-12-17       Impact factor: 12.300

Review 3.  Going to extremes: determinants of extraordinary response and survival in patients with cancer.

Authors:  Flurina A M Saner; Alan Herschtal; Brad H Nelson; Anna deFazio; Ellen L Goode; Susan J Ramus; Ahwan Pandey; Jessica A Beach; Sian Fereday; Andrew Berchuck; Stephanie Lheureux; Celeste Leigh Pearce; Paul D Pharoah; Malcolm C Pike; Dale W Garsed; David D L Bowtell
Journal:  Nat Rev Cancer       Date:  2019-06       Impact factor: 60.716

4.  Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results.

Authors:  Wenya Linda Bi; Lakshmi Nayak; David M Meredith; Joseph Driver; Ziming Du; Samantha Hoffman; Yvonne Li; Eudocia Quant Lee; Rameen Beroukhim; Mikael Rinne; Ricardo McFaline-Figueroa; Ugonma Chukwueke; Christine McCluskey; Sarah Gaffey; Andrew D Cherniack; Jennifer Stefanik; Lisa Doherty; Christina Taubert; Meghan Cifrino; Deborah LaFrankie; Thomas Graillon; Patrick Y Wen; Keith L Ligon; Ossama Al-Mefty; Raymond Y Huang; Alona Muzikansky; E Antonio Chiocca; Sandro Santagata; Ian F Dunn; David A Reardon
Journal:  Neuro Oncol       Date:  2022-01-05       Impact factor: 12.300

5.  Targeting the CSF1/CSF1R axis is a potential treatment strategy for malignant meningiomas.

Authors:  Jacky Yeung; Vesal Yaghoobi; Danielle Miyagishima; Matthew D Vesely; Tianxiang Zhang; Ti Badri; Ala Nassar; Xue Han; Miguel F Sanmamed; Mark Youngblood; Matthieu Peyre; Michel Kalamarides; David L Rimm; Murat Gunel; Lieping Chen
Journal:  Neuro Oncol       Date:  2021-11-02       Impact factor: 12.300

6.  Comparative genomic analysis of driver mutations in matched primary and recurrent meningiomas.

Authors:  Joshua Loewenstern; John Rutland; Corey Gill; Hanane Arib; Margaret Pain; Melissa Umphlett; Yayoi Kinoshita; Russell McBride; Michael Donovan; Robert Sebra; Joshua Bederson; Mary Fowkes; Raj Shrivastava
Journal:  Oncotarget       Date:  2019-05-28

Review 7.  T lymphocyte-targeted immune checkpoint modulation in glioma.

Authors:  William James Kelly; Amber Jin Giles; Mark Gilbert
Journal:  J Immunother Cancer       Date:  2020-02       Impact factor: 13.751

8.  Highly multiplexed immunofluorescence images and single-cell data of immune markers in tonsil and lung cancer.

Authors:  Rumana Rashid; Giorgio Gaglia; Yu-An Chen; Jia-Ren Lin; Ziming Du; Zoltan Maliga; Denis Schapiro; Clarence Yapp; Jeremy Muhlich; Artem Sokolov; Peter Sorger; Sandro Santagata
Journal:  Sci Data       Date:  2019-12-17       Impact factor: 6.444

9.  Grade I meningioma with disseminated bone disease: a rare clinical phenomenon.

Authors:  Oriol Mirallas; David Marmolejo; Augusto Valdivia; Maria Vieito
Journal:  BMJ Case Rep       Date:  2020-04-06

Review 10.  Recent Advances in Meningioma Immunogenetics.

Authors:  May Al-Rashed; Kara Foshay; Malak Abedalthagafi
Journal:  Front Oncol       Date:  2020-01-08       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.